Royal London paid 98.7% of all protection claims made in 2024, posting another record total of more than £751m as 65,385 claims were approved. The figure was £20m more than in 2023,...
Read moreHong Kong-based AIA Group has announced that Mark Tucker will return to AIA to succeed Edmund Sze-Wing Tse as group board chairman as of 1 October 2025. Tucker, who was previously CEO...
Read morePoor mental health, particularly anxiety and low mood, continue to be the primary driver of calls to Zurich's employee assistance helplines. Zurich's Corporate Risk report reveals anxiety and low mood accounted for...
Read moreLegal & General paid £347m in claims across its group risk products in 2024, slightly below its total from 2023. For group income protection (GIP) L&G paid 3,542 claims in 2024, with...
Read moreMost older workers do not benefit from employer-provided insurance products, according to a report from Canada Life. The provider's survey of 600 employers and more than 3,200 members of the UK public...
Read moreReframe Cancer has appointed Russell Young to the newly created role of commercial director. Young (pictured) joins from Further Group UK where he was director of sales and account management and worked...
Read moreWhile Pride celebrations may be in full swing, LGBTQ+ communities - including individuals working across the sector - are more fearful than in previous years as far-right views become more commonplace and...
Read moreIHC has joined group risk industry body Grid. IHC was formed in 1992 to deliver tailored and independent advice to corporate clients which aims to help them select the most suitable insurance...
Read moreGroup income protection could become "much more mainstream" following the Mayfield review. This is according to Christian van Stolk, vice president of Rand Europe, (pictured), who was speaking at Western Provident Association's...
Read moreVanessa Sallows will step down claims and governance director at Legal & General Group Protection at the end of the year to take on a part-time role as claims and clinical development...
Read more